Privium Invests $5M in Denali Therapeutics episode artwork

EPISODE · May 5, 2026 · 1 MIN

Privium Invests $5M in Denali Therapeutics

from The Daily News Now! Business

Privium Fund Management invests $5.07M in Denali Therapeutics, acquiring a 1% stake in the brain-penetrating drug tech company. Denali, focusing on neurodegenerative diseases, recently received FDA approval for Avlayah, its first drug targeting Hunter syndrome symptoms. Shares closed at $18.67, up 18.32% year-to-date, but lagging the S&P 500. Priviums investment, behind Tesla and Shopify, is a high-risk, high-reward bet on Denalis expanding pipeline. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/774079f465405bb4

NOW PLAYING

Privium Invests $5M in Denali Therapeutics

0:00 1:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 5, 2026.

What is this episode about?

Privium Fund Management invests $5.07M in Denali Therapeutics, acquiring a 1% stake in the brain-penetrating drug tech company. Denali, focusing on neurodegenerative diseases, recently received FDA approval for Avlayah, its first drug targeting...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!